Ongoing DAS Projects

The DAS59 and DAS24 are being used internationally in a variety of research and clinical contexts. Some of these are detailed below:

The DAS has been used in clinical and research work in the UK, US and Europe with increasing interest over recent years.  For example, in 2013, along with colleagues in Rome, we published a paper in Aesthetic Plastic Surgery demonstrating differences in older adults appearance well being in Italy and the UK.

The DAS has also been used in the validation of new scales assessing valence and salience of appearance, published in the open access journal PLOS ONE here -

Ben Rosser completes PhD research using DAS24

Ben’s work, at the Centre for Appearance Research, University of the West of England, Bristol, focussed on attentional processes in appearance distress. See downloadable files for one of the studies comprising this work.

Aly Bessell completes PhD research using DAS24

Aly, also at the Centre for Appearance Research, developed an online measure for supporting individuals with appearance distress, FaceIT. She has used the DAS24 to evaluate therapeutic outcomes. She demonstrated a successful outcome for this intervention, in that users improve as much as in face to face sessions, and significantly more than controls, immediately post intervention and at three, six and twelve months.

Kythera Biopharmaceuticals are using the DAS24 in an international trial of a new treatment they have developed.

Healing Foundation Project

The Healing Foundation have provided £500,000 to fund a large multi-centre study into psychosocial adjustment to visible differences of appearance, coordinated from the Centre For Appearance Research at UWE(Bristol), UK. The DAS24 is the main outcome measure of adjustment in this work. The project web site at CAR is Foundation. The principal investigator is Professor Nichola Rumsey. Dr Tim Moss is part of the project team, along with colleagues from UWE, University College London, Warwick University, Sheffield University, Bradford University and the Royal Free Hospital London.

Comments are closed.